MyMammogram for Breast Cancer

This trial tests a tool called MyMammogram to determine if it aids women and their doctors in making better breast cancer screening decisions. It compares three groups: one using MyMammogram with additional doctor communication, one using MyMammogram alone, and one receiving usual care. Women aged 39-49, with an upcoming doctor's appointment, who haven't had a mammogram in the past year, and haven't had breast cancer, are suitable candidates. The trial focuses on how this tool functions in rural healthcare settings. Participants will share their thoughts on the process to help refine the trial. As an unphased trial, this study allows participants to contribute to innovative research that could improve breast cancer screening decisions.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that mammography screening, part of the MyMammogram process, is generally safe for most people. Studies have found that mammography can significantly reduce the risk of dying from breast cancer. However, some possible downsides exist. For example, a false-positive result might occur, suggesting cancer is present when it isn't. Additionally, the procedure uses a small amount of radiation, similar to other common medical imaging tests. Although these risks are considered low, it's important to be aware of them when considering participation in a trial involving MyMammogram.¹²³⁴⁵

Researchers are excited about MyMammogram because it leverages technology to enhance early breast cancer detection. Unlike standard mammography, which relies solely on imaging, MyMammogram combines digital assessment tools with provider communication. This innovative approach not only empowers patients by providing them with actionable insights before their appointments but also equips healthcare providers with a comprehensive summary beforehand. By potentially streamlining the diagnostic process, MyMammogram could lead to quicker and more personalized patient care.

Research shows that mammography screening helps reduce deaths from breast cancer. Studies have found that regular mammograms can detect cancer earlier, which links to lower death rates. For instance, screening women aged 40 to 79 can prevent about 11.5 breast cancer deaths per 1,000 women. Early detection through mammograms often allows for easier treatment. Overall, regular mammography is a proven method in the fight against breast cancer. This trial will evaluate the effectiveness of MyMammogram, with one group using MyMammogram before their appointment and another group using MyMammogram with additional provider communication. A third group will receive usual care.³⁶⁷⁸⁹